Developer docs
API playgroundTry for free, no card

Search company profiles

YD Diagnostics

Full company profile

uuid000o4yv

Namestring
YD Diagnostics
Legal namestring
YD Diagnostics
Company typeenum
Private
Founded yearint
1966
Descriptiontext

YD Diagnostics is a South Korean privately-held in vitro diagnostic (IVD) medical device manufacturer operating for over 40 years. It sells a diversified diagnostic product portfolio organized into six proprietary lines: URiSCAN urine analysis (strips, chemistry analyzers, the PluScope sediment analyzer with microscopic imaging, and quality controls); MolecuTech molecular diagnostics (real-time PCR assays for tuberculosis, HPV, COVID-19, and sexually transmitted infections); ImmunTech rapid immunochromatographic tests (tumor markers, cardiac markers, and fecal occult blood); EASYPREP liquid-based cytology systems; AceChemStain histology and cytology staining reagents; and clinical chemistry reagents. The portfolio spans screening, confirmatory, and monitoring use cases across hospital laboratories, public-health programs, and small-to-mid clinical labs.

The underlying technology is conventional IVD: reflectance photometry and automated microscopy for urine, real-time PCR for molecular targets, lateral-flow immunochromatography for rapid tests, and liquid-based cytology preparation for cell morphology. The PluScope analyzer is the most technologically differentiated instrument, applying multi depth-of-field fusion imaging to urinary sediment particles. Products are cleared by KFDA, hold FDA 510(k) and CE markings where applicable, and are manufactured in Korea.

The business model is B2B export-led: YD Diagnostics sells through international distributors to 116+ countries, with no direct enterprise accounts or framework contracts disclosed. Revenue is generated through instrument placement (urine chemistry analyzers, PluScope, EASYPREP processors) paired with high-margin recurring consumables (strips, PCR reagents, rapid test cassettes, QC materials, staining reagents), creating a razor-and-blade economics for the installed base. No revenue, headcount, funding, or M&A history is publicly disclosed, consistent with its privately-held status.

Short descriptiontext

YD Diagnostics is a privately-held South Korean in vitro diagnostics manufacturer selling urine, molecular, rapid, and cytology testing products through international distributors to 116+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersYongin, South Korea
HQ citystring
Yongin
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
in vitro diagnostics, urine analyzers, molecular diagnostics, clinical chemistry reagents, cytology preparation systems
Industry5 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical Equipment and Supplies Manufacturing3391
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
  • Laboratory Analytical Instruments3826
Product category
In Vitro Diagnostics
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Instruments and Analyzers
TypeHardware Sales
Description

Sale of benchtop and floor-standing diagnostic analyzers including urine chemistry analyzers (URiSCAN Optima, Pro, Super+), urine sediment analyzers (PluScope), and nucleic acid extraction systems (DX32). Instruments provide recurring reagent/consumable revenue.

yd-diagnostics.com
2Reagents and Consumables
TypeSubscription Recurring
Description

Recurring revenue from test strips, cassettes, reagents, control materials, and consumables for diagnostic instruments. Includes URiSCAN urine strips (various configurations), PCR assay kits, clinical chemistry reagents, and cytology supplies.

yd-diagnostics.com
3Quality Control Products
TypeOne Time License
Description

URiTROL liquid and lyophilized urinalysis control products for quality assurance in laboratories.

yd-diagnostics.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1URiSCAN
Description

Urine chemistry analyzers and test strips for urinalysis including URiSCAN Optima, PRO, Super+, and PluScope automated urine sediment analyzer.

yd-diagnostics.com
+4 more records
Core offering1 text field

YD Diagnostics manufactures and sells in vitro diagnostic instruments, reagents, and consumables used by clinical laboratories and hospitals. The portfolio spans automated urine chemistry and sediment analyzers (URiSCAN product family), PCR-based molecular diagnostic assays for infectious diseases (MolecuTech), rapid immunochromatographic tests for cardiac and tumor markers (ImmunTech), liquid-based cytology slide preparation systems (EASYPREP), and laboratory staining reagents (AceChemStain). Instrument placements drive recurring revenue from associated reagent kits and consumables.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • URiSCAN Super+ achieves 200 tests/hour throughput with 400-sample strip loading capacity
+3 more records
Product overview1 text field

YD Diagnostics is a medical diagnostics company offering a diversified portfolio of in vitro diagnostic products across multiple technology platforms. The product portfolio comprises five main brands: URiSCAN (urine analysis systems with reagent strips, automated chemistry and sediment analyzers, and quality controls), MolecuTech (molecular diagnostics for PCR-based detection of tuberculosis, HPV, COVID-19, and STIs with supporting instruments like HybREAD480 and DX32), ImmunTech (rapid immunochromatographic tests for tumor markers, cardiac markers, and fecal occult blood), EASYPREP (liquid-based cytology slide preparation system with reagents and consumables), and AceChemStain (histological staining reagents for cytology and microbiology). The company also offers clinical chemistry reagents for automated analyzers. YD Diagnostics serves clinical laboratories worldwide with products validated across 116 countries and regulatory approvals including FDA, CE, and KFDA.

Product and service15 records
1URiSCAN Urine Reagent Strips
CategoryUrinalysis reagents and consumables
Description

Urine reagent test strips supporting 1-14 parameters including Blood, Bilirubin, Urobilinogen, Ketones, Protein, Nitrite, Glucose, pH, Specific Gravity, Leucocytes, Ascorbic Acid, Microalbumin, and Creatinine, with FDA 510(k) and CE approvals for professional use and self-test.

2URiSCAN Optima Semi-Automatic Urine Analyzer
CategoryDiagnostic instruments
Description

Semi-automatic urine chemistry analyzer with CCD color image sensor, 4.3-inch touch screen TFT LCD, 2,000 test result memory, and throughput of 100 tests per hour (6 seconds in quick mode). Designed for clinical laboratories.

3URiSCAN PRO Semi-Automatic Urine Analyzer
CategoryDiagnostic instruments
Description

Semi-automatic urine analyzer with 7-inch touch screen, 720 tests per hour throughput, closed system for URiSCAN strips, automatic urine color adjustment, and 3,000 patient record memory for clinical laboratory use.

4URiSCAN Super+ Fully Automated Urine Chemistry Analyzer
CategoryDiagnostic instruments
Description

Fully automated urine chemistry analyzer supporting up to 15 parameters with unique 400-test strip loading capacity and 200 tests/hour throughput. Operates standalone or integrated with URiSCAN PluScope, with KFDA approval.

5URiSCAN PluScope Automated Urine Sediment Analyzer
CategoryDiagnostic instruments
Description

High-end fully automated urine sediment analyzer using microscopic imaging analysis with multi-depth field fusion, providing 18 reportable parameters including RBC, WBC, bacteria, crystals, and casts at 120 tests per hour. KFDA approved.

6URiTROL Urinalysis Quality Control
CategoryQuality control products
Description

Assayed quality control urine material for monitoring accuracy and precision of URiSCAN urine strips and analyzers, available in liquid ready-to-use and lyophilized formats for laboratory quality assurance programs.

7MolecuTech TB Detection Assays
CategoryMolecular diagnostic assays
Description

PCR-based assay systems for detection and differentiation of Mycobacterium tuberculosis (MTB) including TB-Tag Two (nested PCR), MTB-ID V3 (MTB/NTM differentiation), Real TB-Tag (real-time PCR), and REBA assays for MDR/XDR drug resistance profiling.

8MolecuTech HPV Genotyping Assays
CategoryMolecular diagnostic assays
Description

REBA HPV-ID reverse blot hybridization assay identifying 32 HPV genotypes (18 high-risk, 1 medium-risk, 13 low-risk) and Real HPV 16/18/HR real-time PCR assay for HPV 16, 18, and 12 high-risk types for cervical cancer screening.

9MolecuTech STI and COVID-19 Real-Time PCR Assays
CategoryMolecular diagnostic assays
Description

Real-time PCR assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae (Real CT/NG), Herpes Simplex Virus types 1 and 2 (Real HSV 1/2), and SARS-CoV-2 plus pan-coronavirus detection (Real-Time COVID-19) with 2-hour turnaround.

10HybREAD480 Automated REBA Processor
CategoryDiagnostic instruments
Description

Fully automated strip assay processor handling sample preparation through result interpretation for REBA assays, with capacity for 48 samples, CMOS camera detection, and built-in UV lamp for contamination prevention.

11DX32 Automated Nucleic Acid Purification System
CategoryDiagnostic instruments
Description

Automated nucleic acid extraction platform using Magnetic Pillar technology, processing up to 32 samples in 40 minutes with built-in UV decontamination, paired with extraction kits for viral DNA/RNA, bacterial, whole blood, and tissue genomic DNA.

12ImmunTech Rapid Immunoassays (Cardiac and Tumor Markers)
CategoryImmunoassay rapid tests
Description

Rapid immunochromatographic cassette tests including OcculTech FOB (fecal occult blood, 100% sensitivity, 98.9% specificity), AFP (tumor marker), CEA (tumor marker), PSA (prostate-specific antigen), and Cardiac Triple Test (Troponin I, CK-MB, Myoglobin) with 5-15 minute results.

13Clinical Chemistry Reagents
CategoryClinical chemistry reagents
Description

Reagents for automated clinical chemistry analyzers including assays for AST, ALT, Glucose, ALP, Amylase, Creatinine, Uric Acid, Cholesterol, HDL-C, LDL-C, Calcium, Bilirubin, Total Protein, Albumin, Phosphorus, Triglycerides, gamma-GT, BUN, LDH, CK-NAC, and Hemoglobin, plus lipid profile reagents.

14EASYPREP Liquid-Based Cytology System
CategoryCytology preparation systems
Description

Automated liquid-based cytology processor using sedimentation and centrifuge method with built-in centrifuge, 56 tests per hour throughput, KFDA and CE certified, paired with methanol/isopropanol-free preservative solution and reagent kits for cervical and non-gynecologic specimens.

15AceChemStain Laboratory Staining Reagents
CategoryLaboratory staining reagents
Description

Laboratory staining reagents for cytology and microbiology including Papanicolaou Stain (Harris Hematoxylin and Gill's-II variants), AFB Stain (Ziehl-Neelsen method), Gram Stain (gram-positive/negative differentiation), and Wright Stain (differential blood cell count).

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Women's health and molecular diagnostics specialist with ThinPrep liquid-based cytology, Panther molecular systems, and Aptima HPV/STI assays. Competes with YD's EASYPREP cytology and MolecuTech HPV/CT/NG portfolios.

TypeDirect peer
Description

Global leader in urinalysis (UF-series) and hematology analyzers with proprietary urine sediment analysis. Direct competitor to YD's URiSCAN PluScope and Super+ in mid- and high-throughput clinical labs worldwide.

3Beckman Coulter Diagnostics
TypeBroad incumbent
Description

Large IVD incumbent offering urine chemistry analyzers, clinical chemistry, and immunoassay reagents globally. Competes with YD's clinical chemistry reagents and URiSCAN line in routine and reference laboratories.

TypeEmerging player
Description

Mid-tier global IVD manufacturer offering clinical chemistry, urine chemistry analyzers, and hematology systems targeted at emerging markets. Comparable mid-tier positioning to YD with overlapping urinalysis and chemistry product lines.

TypeDirect peer
Description

Leader in automated molecular diagnostics with GeneXpert systems for TB (Xpert MTB/RIF), CT/NG, HPV, and COVID-19. Direct competitor to YD's MolecuTech molecular assays in the same disease areas.

TypeDirect peer
Description

Chinese IVD manufacturer with broad urinalysis, clinical chemistry, and hematology analyzer lines plus reagent strips. Competes head-to-head with YD in emerging markets and on price-sensitive hospital tenders.

TypeRegional player
Description

Korean IVD company focused on rapid immunochromatographic tests (cardiac, tumor, infectious disease markers) and hemoglobin analyzers. Closest Korean peer to YD's ImmunTech rapid immunoassay line.

TypeDirect peer
Description

Korean molecular diagnostics company specializing in multiplex PCR assays for infectious diseases, including TB, HPV, CT/NG, and COVID-19. Closest direct Korean peer to YD's MolecuTech PCR/REBA product line.

TypeBroad incumbent
Description

World's largest IVD player with cobas analyzers, urine screening strips, and molecular diagnostics (including TB and HPV). Overlaps with nearly all of YD's product families as a broad portfolio incumbent.

TypeBroad incumbent
Description

Major IVD vendor with ADVIA Centaur and Atellica clinical chemistry/immunoassay analyzers plus urine analysis reagents. Competes with YD in clinical chemistry, immunoassays, and routine urine workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

YD Diagnostics

In Vitro Diagnosticsyd-diagnostics.com

YD Diagnostics is a privately-held South Korean in vitro diagnostics manufacturer selling urine, molecular, rapid, and cytology testing products through international distributors to 116+ countries.

What YD Diagnostics does

YD Diagnostics is a South Korean privately-held in vitro diagnostic (IVD) medical device manufacturer operating for over 40 years. It sells a diversified diagnostic product portfolio organized into six proprietary lines: URiSCAN urine analysis (strips, chemistry analyzers, the PluScope sediment analyzer with microscopic imaging, and quality controls); MolecuTech molecular diagnostics (real-time PCR assays for tuberculosis, HPV, COVID-19, and sexually transmitted infections); ImmunTech rapid immunochromatographic tests (tumor markers, cardiac markers, and fecal occult blood); EASYPREP liquid-based cytology systems; AceChemStain histology and cytology staining reagents; and clinical chemistry reagents. The portfolio spans screening, confirmatory, and monitoring use cases across hospital laboratories, public-health programs, and small-to-mid clinical labs.

The underlying technology is conventional IVD: reflectance photometry and automated microscopy for urine, real-time PCR for molecular targets, lateral-flow immunochromatography for rapid tests, and liquid-based cytology preparation for cell morphology. The PluScope analyzer is the most technologically differentiated instrument, applying multi depth-of-field fusion imaging to urinary sediment particles. Products are cleared by KFDA, hold FDA 510(k) and CE markings where applicable, and are manufactured in Korea.

The business model is B2B export-led: YD Diagnostics sells through international distributors to 116+ countries, with no direct enterprise accounts or framework contracts disclosed. Revenue is generated through instrument placement (urine chemistry analyzers, PluScope, EASYPREP processors) paired with high-margin recurring consumables (strips, PCR reagents, rapid test cassettes, QC materials, staining reagents), creating a razor-and-blade economics for the installed base. No revenue, headcount, funding, or M&A history is publicly disclosed, consistent with its privately-held status.

YD Diagnostics firmographics

Firmographics
Name
YD Diagnostics
Legal name
YD Diagnostics
Website
https://yd-diagnostics.com
Company type
Private
Founded year
1966
Operating status
Operating
Headcount range
51–100 employees
Short description
YD Diagnostics is a privately-held South Korean in vitro diagnostics manufacturer selling urine, molecular, rapid, and cytology testing products through international distributors to 116+ countries.
Ownership category
akta.pro rank

YD Diagnostics industry classification

Industry
Product category
In Vitro Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • In vitro diagnostics
  • Urine analyzers
  • Molecular diagnostics
  • Clinical chemistry reagents
  • Cytology preparation systems

Where YD Diagnostics is headquartered

Location

Headquarters

HQ city
Yongin
HQ country
South Korea
HQ region
Asia

Markets served

YD Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Diagnostic Instruments and Analyzers: Sale of benchtop and floor-standing diagnostic analyzers including urine chemistry analyzers (URiSCAN Optima, Pro, Super+), urine sediment analyzers (PluScope), and nucleic acid extraction systems (DX32). Instruments provide recurring reagent/consumable revenue.
  2. Reagents and Consumables: Recurring revenue from test strips, cassettes, reagents, control materials, and consumables for diagnostic instruments. Includes URiSCAN urine strips (various configurations), PCR assay kits, clinical chemistry reagents, and cytology supplies.
  3. Quality Control Products: URiTROL liquid and lyophilized urinalysis control products for quality assurance in laboratories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

YD Diagnostics product offering

Product offering

Core offering

YD Diagnostics manufactures and sells in vitro diagnostic instruments, reagents, and consumables used by clinical laboratories and hospitals. The portfolio spans automated urine chemistry and sediment analyzers (URiSCAN product family), PCR-based molecular diagnostic assays for infectious diseases (MolecuTech), rapid immunochromatographic tests for cardiac and tumor markers (ImmunTech), liquid-based cytology slide preparation systems (EASYPREP), and laboratory staining reagents (AceChemStain). Instrument placements drive recurring revenue from associated reagent kits and consumables.

Product overview

YD Diagnostics is a medical diagnostics company offering a diversified portfolio of in vitro diagnostic products across multiple technology platforms. The product portfolio comprises five main brands: URiSCAN (urine analysis systems with reagent strips, automated chemistry and sediment analyzers, and quality controls), MolecuTech (molecular diagnostics for PCR-based detection of tuberculosis, HPV, COVID-19, and STIs with supporting instruments like HybREAD480 and DX32), ImmunTech (rapid immunochromatographic tests for tumor markers, cardiac markers, and fecal occult blood), EASYPREP (liquid-based cytology slide preparation system with reagents and consumables), and AceChemStain (histological staining reagents for cytology and microbiology). The company also offers clinical chemistry reagents for automated analyzers. YD Diagnostics serves clinical laboratories worldwide with products validated across 116 countries and regulatory approvals including FDA, CE, and KFDA.

Differentiator

Problem solved

Functional benefit

Brands

  • URiSCAN: Urine chemistry analyzers and test strips for urinalysis including URiSCAN Optima, PRO, Super+, and PluScope automated urine sediment analyzer.
  • MolecuTech
  • ImmunTech
  • EASYPREP
  • AceChemStain

Products and services

  • URiSCAN Urine Reagent Strips Urine reagent test strips supporting 1-14 parameters including Blood, Bilirubin, Urobilinogen, Ketones, Protein, Nitrite, Glucose, pH, Specific Gravity, Leucocytes, Ascorbic Acid, Microalbumin, and Creatinine, with FDA 510(k) and CE approvals for professional use and self-test.
  • URiSCAN Optima Semi-Automatic Urine Analyzer Semi-automatic urine chemistry analyzer with CCD color image sensor, 4.3-inch touch screen TFT LCD, 2,000 test result memory, and throughput of 100 tests per hour (6 seconds in quick mode). Designed for clinical laboratories.
  • URiSCAN PRO Semi-Automatic Urine Analyzer Semi-automatic urine analyzer with 7-inch touch screen, 720 tests per hour throughput, closed system for URiSCAN strips, automatic urine color adjustment, and 3,000 patient record memory for clinical laboratory use.
  • URiSCAN Super+ Fully Automated Urine Chemistry Analyzer Fully automated urine chemistry analyzer supporting up to 15 parameters with unique 400-test strip loading capacity and 200 tests/hour throughput. Operates standalone or integrated with URiSCAN PluScope, with KFDA approval.
  • URiSCAN PluScope Automated Urine Sediment Analyzer High-end fully automated urine sediment analyzer using microscopic imaging analysis with multi-depth field fusion, providing 18 reportable parameters including RBC, WBC, bacteria, crystals, and casts at 120 tests per hour. KFDA approved.
  • URiTROL Urinalysis Quality Control Assayed quality control urine material for monitoring accuracy and precision of URiSCAN urine strips and analyzers, available in liquid ready-to-use and lyophilized formats for laboratory quality assurance programs.
  • MolecuTech TB Detection Assays PCR-based assay systems for detection and differentiation of Mycobacterium tuberculosis (MTB) including TB-Tag Two (nested PCR), MTB-ID V3 (MTB/NTM differentiation), Real TB-Tag (real-time PCR), and REBA assays for MDR/XDR drug resistance profiling.
  • MolecuTech HPV Genotyping Assays REBA HPV-ID reverse blot hybridization assay identifying 32 HPV genotypes (18 high-risk, 1 medium-risk, 13 low-risk) and Real HPV 16/18/HR real-time PCR assay for HPV 16, 18, and 12 high-risk types for cervical cancer screening.
  • MolecuTech STI and COVID-19 Real-Time PCR Assays Real-time PCR assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae (Real CT/NG), Herpes Simplex Virus types 1 and 2 (Real HSV 1/2), and SARS-CoV-2 plus pan-coronavirus detection (Real-Time COVID-19) with 2-hour turnaround.
  • HybREAD480 Automated REBA Processor Fully automated strip assay processor handling sample preparation through result interpretation for REBA assays, with capacity for 48 samples, CMOS camera detection, and built-in UV lamp for contamination prevention.
  • DX32 Automated Nucleic Acid Purification System Automated nucleic acid extraction platform using Magnetic Pillar technology, processing up to 32 samples in 40 minutes with built-in UV decontamination, paired with extraction kits for viral DNA/RNA, bacterial, whole blood, and tissue genomic DNA.
  • ImmunTech Rapid Immunoassays (Cardiac and Tumor Markers) Rapid immunochromatographic cassette tests including OcculTech FOB (fecal occult blood, 100% sensitivity, 98.9% specificity), AFP (tumor marker), CEA (tumor marker), PSA (prostate-specific antigen), and Cardiac Triple Test (Troponin I, CK-MB, Myoglobin) with 5-15 minute results.
  • Clinical Chemistry Reagents Reagents for automated clinical chemistry analyzers including assays for AST, ALT, Glucose, ALP, Amylase, Creatinine, Uric Acid, Cholesterol, HDL-C, LDL-C, Calcium, Bilirubin, Total Protein, Albumin, Phosphorus, Triglycerides, gamma-GT, BUN, LDH, CK-NAC, and Hemoglobin, plus lipid profile reagents.
  • EASYPREP Liquid-Based Cytology System Automated liquid-based cytology processor using sedimentation and centrifuge method with built-in centrifuge, 56 tests per hour throughput, KFDA and CE certified, paired with methanol/isopropanol-free preservative solution and reagent kits for cervical and non-gynecologic specimens.
  • AceChemStain Laboratory Staining Reagents Laboratory staining reagents for cytology and microbiology including Papanicolaou Stain (Harris Hematoxylin and Gill's-II variants), AFB Stain (Ziehl-Neelsen method), Gram Stain (gram-positive/negative differentiation), and Wright Stain (differential blood cell count).

Quantifiable outcome

  • URiSCAN Super+ achieves 200 tests/hour throughput with 400-sample strip loading capacity
  • +3 more outcomes

Companies that use YD Diagnostics

Customer profile

Segments3 records

Ideal customer profiles3 records

YD Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

Feature6 records

YD Diagnostics partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

YD Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • Hologic: Women's health and molecular diagnostics specialist with ThinPrep liquid-based cytology, Panther molecular systems, and Aptima HPV/STI assays. Competes with YD's EASYPREP cytology and MolecuTech HPV/CT/NG portfolios.
  • Beckman Coulter Diagnostics: Large IVD incumbent offering urine chemistry analyzers, clinical chemistry, and immunoassay reagents globally. Competes with YD's clinical chemistry reagents and URiSCAN line in routine and reference laboratories.
  • Roche Diagnostics: World's largest IVD player with cobas analyzers, urine screening strips, and molecular diagnostics (including TB and HPV). Overlaps with nearly all of YD's product families as a broad portfolio incumbent.
  • Siemens Healthineers: Major IVD vendor with ADVIA Centaur and Atellica clinical chemistry/immunoassay analyzers plus urine analysis reagents. Competes with YD in clinical chemistry, immunoassays, and routine urine workflows.

Direct peers

  • Sysmex: Global leader in urinalysis (UF-series) and hematology analyzers with proprietary urine sediment analysis. Direct competitor to YD's URiSCAN PluScope and Super+ in mid- and high-throughput clinical labs worldwide.
  • Cepheid (Danaher): Leader in automated molecular diagnostics with GeneXpert systems for TB (Xpert MTB/RIF), CT/NG, HPV, and COVID-19. Direct competitor to YD's MolecuTech molecular assays in the same disease areas.
  • Mindray: Chinese IVD manufacturer with broad urinalysis, clinical chemistry, and hematology analyzer lines plus reagent strips. Competes head-to-head with YD in emerging markets and on price-sensitive hospital tenders.
  • Seegene: Korean molecular diagnostics company specializing in multiplex PCR assays for infectious diseases, including TB, HPV, CT/NG, and COVID-19. Closest direct Korean peer to YD's MolecuTech PCR/REBA product line.

Emerging players

  • Erba Mannheim: Mid-tier global IVD manufacturer offering clinical chemistry, urine chemistry analyzers, and hematology systems targeted at emerging markets. Comparable mid-tier positioning to YD with overlapping urinalysis and chemistry product lines.

Regional players

  • SD Biosensor: Korean IVD company focused on rapid immunochromatographic tests (cardiac, tumor, infectious disease markers) and hemoglobin analyzers. Closest Korean peer to YD's ImmunTech rapid immunoassay line.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

YD Diagnostics compliance and trust

Trust signal

Compliance6 records

YD Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

YD Diagnostics leadership team

Management profile

Number of profiles

YD Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

YD Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YD Diagnostics

What does YD Diagnostics do?

YD Diagnostics manufactures and sells in vitro diagnostic instruments, reagents, and consumables used by clinical laboratories and hospitals. The portfolio spans automated urine chemistry and sediment analyzers (URiSCAN product family), PCR-based molecular diagnostic assays for infectious diseases (MolecuTech), rapid immunochromatographic tests for cardiac and tumor markers (ImmunTech), liquid-based cytology slide preparation systems (EASYPREP), and laboratory staining reagents (AceChemStain). Instrument placements drive recurring revenue from associated reagent kits and consumables.

Is YD Diagnostics a public or private company?

YD Diagnostics is a private company. It is classified as unknown and is currently operating.

When was YD Diagnostics founded?

YD Diagnostics was founded in 1966. It employs 51 to 100 people.

Where is YD Diagnostics based?

YD Diagnostics is headquartered in Yongin, South Korea, in the Asia region.

How does YD Diagnostics make money?

Three revenue lines are on record. Diagnostic Instruments and Analyzers are the primary driver. The others are reagents and Consumables and quality Control Products.

Who are YD Diagnostics's main competitors?

Broad incumbents on record are Hologic, Beckman Coulter Diagnostics, Roche Diagnostics and Siemens Healthineers. Direct peers are Sysmex, Cepheid (Danaher), Mindray and Seegene. Erba Mannheim is listed as an emerging player. SD Biosensor is listed as a regional player.

Does YD Diagnostics have an API?

No public API is recorded for YD Diagnostics.

What industry is YD Diagnostics in?

YD Diagnostics's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales